Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Abbott Laboratories et al v. Teva Pharmaceutical Industries Ltd. et al
Case Number:
1:11-cv-00239
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 04, 2012
Abbott Drops Patent Claims Over Teva's Generic Simcor
Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.
-
March 23, 2011
Abbott Files New Simcor Patent Suit Against Teva
Abbott Laboratories launched another patent infringement suit in Delaware on Monday against generic-drug maker Teva Pharmaceutical Industries Ltd. in an effort to protect the market for cholesterol treatment Simcor.